The FDA launches its PreCheck Program to speed up approvals, while the FTC moves to block Edwards Lifesciences' acquisition of JenaValve. Leadership changes at an FDA center may impact future timelines.
Comments
0
Be the first to comment
Sign up now and become a member of the 5-Minute Pharma Daily community!
Comments
0Be the first to comment
Sign up now and become a member of the 5-Minute Pharma Daily community!